← Leaderboards
David Wang
Washington University
$34,713,611
Attributed
$37,436,975
Total exposure
18
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,436,975 · 18
By mechanism
U01$12,244,907 · 2
RC2$8,939,906 · 1
R01$4,575,488 · 2
U54$3,785,041 · 1
R21$3,745,882 · 9
R33$2,107,459 · 1
Top collaborators
- Corey Casper4 shared
- Denise A. Galloway4 shared
- Margaret M Madeleine4 shared
- Rudolf P Bohm2 shared
Most similar at Washington University
Same institution · by research overlap
- Adrianus Cm Boon$7,930,780
- Daved H Fremont$19,011,013
- Sean P. J. Whelan$36,954,740
- Herbert W Virgin$43,147,000
- William A Frazier$7,571,651
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusViralInfectionFamilyPlayAnimal ModelVirus DiseasesSpecimenNovel VirusVirologyPathogenEtiologyPathogenesisCellsBiologyBaseCell Culture TechniquesBioinformaticsGeneticCell Culture SystemMicrobialGenesPathway InteractionsCohort
Grant awards (54)
Identification of evolutionarily conserved pro-viral and anti-viral host factors from worms to mammals$226,253
R21 · FY2025 · AI · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$1,615,955
U01 · FY2024 · AI · contact PI
Identification of evolutionarily conserved pro-viral and anti-viral host factors from worms to mammals$194,375
R21 · FY2024 · AI · contact PI
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)$1,673,377
RC2 · FY2023 · DK · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$1,598,955
U01 · FY2023 · AI · contact PI
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)$1,753,001
RC2 · FY2022 · DK · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$1,613,395
U01 · FY2022 · AI · contact PI
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.$393,750
R01 · FY2022 · AI · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$247,061
U01 · FY2022 · AI · contact PI
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)$1,809,005
RC2 · FY2021 · DK · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$1,614,920
U01 · FY2021 · AI · contact PI
THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION$713,714
R33 · FY2021 · HL · contact PI
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.$393,750
R01 · FY2021 · AI · contact PI
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)$1,832,307
RC2 · FY2020 · DK · contact PI
Emerging infections: surveillance, epidemiology and pathogenesis$1,683,114
U01 · FY2020 · AI · contact PI
THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION$698,349
R33 · FY2020 · HL · contact PI
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.$393,541
R01 · FY2020 · AI · contact PI
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)$1,872,216
RC2 · FY2019 · DK · contact PI
THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION$695,396
R33 · FY2019 · HL · contact PI
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.$391,875
R01 · FY2019 · AI · contact PI
PRIMATE INFECTIOUS DISEASE RESOURCE (PIDR)$781,600
R24 · FY2018 · OD · contact PI
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.$387,500
R01 · FY2018 · AI · contact PI
THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION$254,922
R61 · FY2018 · HL · contact PI
PROPAGATION OF THE EMERGING ENCEPHALITIC VIRUS ASTROVIRUS VA1$228,750
R21 · FY2018 · NS · contact PI
RECOGNITION AND SIGNALING OF VIRAL INFECTION IN C. ELEGANS$190,625
R21 · FY2018 · AI · contact PI
PRIMATE INFECTIOUS DISEASE RESOURCE (PIDR)$742,520
R24 · FY2017 · OD · contact PI
THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION$259,250
R61 · FY2017 · HL · contact PI
RECOGNITION AND SIGNALING OF VIRAL INFECTION IN C. ELEGANS$228,750
R21 · FY2017 · AI · contact PI
PROPAGATION OF THE EMERGING ENCEPHALITIC VIRUS ASTROVIRUS VA1$190,625
R21 · FY2017 · NS · contact PI
NOVEL NEMATODE MODELS FOR VIRAL INFECTION$190,625
R21 · FY2016 · AI · contact PI
DETECTION AND DISCOVERY OF VIRUSES IN PEDIATRIC ACUTE LIVER FAILURE$190,625
R21 · FY2016 · AI · contact PI
NOVEL ANTIVIRAL IMMUNITY IN C. ELEGANS$190,625
R21 · FY2016 · AI · contact PI
Novel Pathogen Associated Cancers (PQ12)$371,081
R01 · FY2015 · CA
NOVEL ANTIVIRAL IMMUNITY IN C. ELEGANS$228,750
R21 · FY2015 · AI · contact PI
NOVEL NEMATODE MODELS FOR VIRAL INFECTION$228,750
R21 · FY2015 · AI · contact PI
DETECTION AND DISCOVERY OF VIRUSES IN PEDIATRIC ACUTE LIVER FAILURE$228,750
R21 · FY2015 · AI · contact PI
Novel Pathogen Associated Cancers (PQ12)$722,856
R01 · FY2014 · CA
Discovery and characterization of emerging, engineered and unrecognized pathogens$983,001
U54 · FY2013 · AI · contact PI
Novel Pathogen Associated Cancers (PQ12)$736,412
R01 · FY2013 · CA
EXPLORING THE C. ELEGANS TRANSCRIPTIONAL RESPONSE TO VIRAL INFECTION$190,000
R21 · FY2013 · AI · contact PI
Discovery and characterization of emerging, engineered and unrecognized pathogens$974,880
U54 · FY2012 · AI · contact PI
Novel Pathogen Associated Cancers (PQ12)$784,723
R01 · FY2012 · CA
EXPLORING THE C. ELEGANS TRANSCRIPTIONAL RESPONSE TO VIRAL INFECTION$228,000
R21 · FY2012 · AI · contact PI
ESTABLISHMENT OF A REPLICATION SYSTEM FOR WU POLYOMAVIRUS$190,000
R21 · FY2012 · AI · contact PI
Discovery and characterization of emerging, engineered and unrecognized pathogens$882,546
U54 · FY2011 · AI · contact PI
ESTABLISHMENT OF A REPLICATION SYSTEM FOR WU POLYOMAVIRUS$244,000
R21 · FY2011 · AI · contact PI
EPIDEMIOLOGY OF NOVEL HUMAN ASTROVIRUSES$168,379
R21 · FY2011 · AI · contact PI
Discovery and characterization of emerging, engineered and unrecognized pathogens$944,614
U54 · FY2010 · AI · contact PI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses$784,825
U01 · FY2010 · AI · contact PI
EPIDEMIOLOGY OF NOVEL HUMAN ASTROVIRUSES$208,000
R21 · FY2010 · AI · contact PI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses$772,287
U01 · FY2009 · AI · contact PI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses$752,416
U01 · FY2008 · AI · contact PI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses$836,462
U01 · FY2007 · AI · contact PI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses$725,517
U01 · FY2006 · AI · contact PI